Status:

RECRUITING

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions:

Organoids

Breast Cancer

Eligibility:

FEMALE

18-70 years

Brief Summary

Breast cancer is the most common malignancy in women worldwide. Patients with breast cancer are often diagnosed at later stages and have a strong desire for breast conservation, necessitating neoadjuv...

Detailed Description

58 early-stage breast cancer patients scheduled to undergo neoadjuvant therapy will be recruited. Baseline information including medical history, ultrasound, Breast-Specific Gamma Imaging (BSGI), and ...

Eligibility Criteria

Inclusion

  • Signed informed consent form and willingness to participate in the clinical study.
  • Female patients aged between 18 and 70 years old.
  • Confirmed early-stage breast cancer eligible for surgery (AJCC stages I to IIIA), with a tumor diameter of ≥ 2cm detected by MRI and without distant metastasis (M0).
  • The largest lesion among multiple lesions has a diameter of ≥ 2cm.
  • ECOG performance status score of 0-1.
  • No significant abnormalities in liver and kidney function (BIL \<1.5-fold upper limit of normal (ULN);ALT\<2.5×ULN; AST\<2.5×ULN;Crea≤1×ULN).

Exclusion

  • Received prior treatments.
  • Locally advanced breast cancer not amenable to surgery or inflammatory breast cancer (AJCC stage unresectable III).
  • Bilateral breast cancer.
  • Multiple breast cancers distributed in different quadrants.
  • Patients not suitable for neoadjuvant chemotherapy.

Key Trial Info

Start Date :

December 6 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT06155305

Start Date

December 6 2023

End Date

December 1 2025

Last Update

January 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

2 nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, Zhejiang, China, 310009